Table 3 Treatments used in patients with HLA-B27-associated uveitis

Systemic medications (N = 39)

 Oral Corticosteroid

n = 8 (20.5%)

 Intravenous Corticosteroid

n = 0

 Intravitreal Corticosteroid

n = 0

 Subconjunctival Corticosteroid

n = 5 (12.8%)

 Methotrexate

n = 9 (23%)

 Azathioprine

n = 1 (2.6%)

 Sulfazalazine

n = 2 (5.1%)

 Rituximab

n = 1 (2.6%)

 Infliximab

n = 4 (10.3%)

 Etanercept

n = 2 (5.1%)

 Adalimumab

n = 5 (12.8%)

 Certolizumab

n = 2 (5.1%)

 Golimumab

n = 2 (5.1%)

 MTX + ADA

n = 7 (17.9%)

Topical medications (N = 39)

 Corticosteroid

n = 30 (76.9%)

 Hypotensor

n = 5 (12.8%)

 Mydriatic

n = 14 (35.9%)

 NSAIDs

n = 23 (59%)